Long Term Safety of Alpha1-Proteinase Inhibitor in Subjects With Alpha1 Antitrypsin Deficiency

NCT02796937 · clinicaltrials.gov ↗
PHASE3
Phase
ENROLLING_BY_INVITATION
Status
290
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Grifols Therapeutics LLC